DI 23022.165:
Friedreich's Ataxia (FRDA)
Effective Dates: 12/02/2016 - Present- Effective Dates: 03/28/2018 - Present
TN 1 (10-08)- TN 16 (03-18)
- DI 23022.165 Friedreich's Ataxia (FRDA)
- COMPASSIONATE ALLOWANCE INFORMATION
- FRIEDREICH'S ATAXIA (FRDA)
- DESCRIPTION
- Friedreich's Ataxia (FRDA) is an inherited disease that causes progressive damage to the nervous system resulting in symptoms ranging from muscle weakness and speech problems to heart disease. Ataxia results from the degeneration of nerve tissue in the spinal cord and of nerves that control muscle movement in the arms and legs. Symptoms usually begin between the ages of 5 and 15 but can appear as early as 18 months or as late as 30 years of age. The first symptom is usually difficulty in walking. The ataxia gradually worsens and slowly spreads to the arms and then the trunk. Foot deformities such as clubfoot, flexion (involuntary bending) of the toes, hammer toes, or foot inversion (turning in) may be early signs. Rapid, rhythmic, involuntary movements of the eyeball are common. Most people with FRDA develop scoliosis (a curving of the spine to one side), which, if severe, may impair breathing. Other symptoms include chest pain, shortness of breath, and heart palpitations.
- ALTERNATE NAMES
- Friedreich's Disease, Friedreich's Tabes, Hereditary Ataxia-Friedreich's type, Hereditofamilial Spinal Ataxia
- DIAGNOSTIC TESTING AND CODING
- Diagnosis of FRDA includes clinical examination, which includes a medical history and a thorough physical examination. Several tests may be helpful, including nerve conduction studies, electromyogram (EMG), electrocardiogram, MRI, blood tests and urinalysis, and holter monitor. Genetic testing can confirm the chromosomal abnormality that causes this disease. Evidence of positive gene testing and gait ataxia is necessary to determine the underlying gene abnormality that results in this disease to confirm the diagnosis of FRDA.
- TREATMENT
- There is currently no effective cure or treatment for FRDA. However, many of the symptoms and accompanying complications can be treated to help patients maintain optimal functioning as long as possible. Diabetes and heart problems can be treated with medications. Orthopedic problems such as foot deformities and scoliosis can be treated with braces or surgery. Physical therapy may prolong use of the arms and legs.
- PROGRESSION
- The FRDA gene is present at birth. Generally, within 15 to 20 years after the appearance of the first symptoms, the person is confined to a wheelchair, and in later stages of the disease, individuals become completely incapacitated. Most people with FRDA die in early adulthood if there is significant heart disease, the most common cause of death. Some people with less severe symptoms live much longer.
- SUGGESTED PROGRAMMATIC ASSESSMENT*
- Suggested MER for Evaluation: Genetic testing for the FRDA gene, clinical evaluation with history and complete neurological examination.
- Suggested Listings for Evaluation:
- DETERMINATION
- LISTING
- REMARKS
- Meets Listing
- 11.17
-
-
- 111.17
-
- Medical Equals
-
-
- * Adjudicators may, at their discretion, use the Medical Evidence of Record or Listings suggested to evaluate the claim. However, the decision to allow or deny the claim rests with the adjudicator.
Last Updated: 9/30/08Office of Disability Programs
x
← This means that the line
was removed and
was added – in other words, the "Effective Dates" line at the top of the document has been updated to reflect that the new version is effective as of the date the change was made.